<DOC>
	<DOCNO>NCT00293046</DOCNO>
	<brief_summary>This trial perform assess whether Grazax® treatment compliance improve use compliance device ( Memozax® ) .</brief_summary>
	<brief_title>Assessment Grazax® Treatment Compliance</brief_title>
	<detailed_description />
	<criteria>Grass pollen induce rhinoconjunctivitis Males female , 1865 year age Positive skin prick test Previous treatment grass pollen allergen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Allergy</keyword>
</DOC>